Chronic Endometritis and IVF: Silent Inflammation, Biopsy & Treatment

Medically reviewed on 28 August 2026 - Dr. Senai Aksoy
A clean clinical consultation desk with a closed slide-storage box and an unlabeled biopsy sampler under soft natural light

Key Takeaways

Chronic endometritis is a persistent, low-grade inflammation of the uterine lining. It differs from acute endometritis: symptoms may be mild or absent, yet the endometrium may still be less favorable for implantation. Diagnosis usually requires an endometrial biopsy with plasma-cell (CD138) staining — not ultrasound alone.

Key evidence: Kimura et al. — Review: Chronic endometritis and its effect on reproduction (2019) ESHRE Good Practice Recommendations on Recurrent Implantation Failure (2023) Wei et al. 2026 — antibiotic cure and subsequent FET outcomes

On this page

When silent lining inflammation matters for IVF

Some pelvic infections announce themselves: fever, pain, and a clear sense of urgency.

Chronic endometritis usually does not. It is a low-grade, persistent inflammation of the uterine lining. Immune cells — especially plasma cells — linger in the endometrium. You may feel entirely well, and the lining can still be less receptive for implantation.

That silence is why a routine pelvic ultrasound so often misses it. Ultrasound alone rarely proves the diagnosis. Confirmation usually needs an endometrial biopsy with plasma-cell staining (often CD138). The biopsy is sometimes done after hysteroscopy, when the cavity looks irregular or when implantation has failed more than once.

This is why the condition comes up in discussions of recurrent implantation failure, recurrent pregnancy loss, or unexplained infertility. Couples travelling for IVF abroad should bring prior biopsy or hysteroscopy reports when they have them. The receiving team can then decide whether the cavity needs another look before transfer.

Why it matters in IVF

Confirmed chronic endometritis is linked with poorer reproductive outcomes in selected groups, especially after repeated IVF failure. It does not explain every failed cycle, and it is not a reason to screen every patient automatically.

Chronic inflammation can change local immune signalling and the surface of the endometrium. That may interfere with implantation or with early placental blood-vessel development (Kimura et al., 2019). Confirmed cases are more often seen alongside lower live-birth rates, particularly after more than one unsuccessful transfer.

Not every failed IVF attempt comes from lining inflammation. Testing should not become an automatic extra for a first cycle. When the history genuinely raises concern, chronic endometritis is worth investigating — together with embryo chromosomal quality, transfer technique, and structural findings in the cavity.

Why it is easy to miss

Many women have no symptoms. Others notice only subtle spotting or mild pelvic discomfort that also occurs in ordinary cycles. Symptoms alone cannot confirm or exclude the condition.

Some women notice nothing at all. Others may occasionally have:

None of these signs is specific enough to make the diagnosis. Ordinary cycle variation can look the same.

Acute endometritis is a different picture. Fever or marked pelvic pain, particularly after childbirth, miscarriage, or an intrauterine procedure, calls for prompt medical assessment (StatPearls, 2024).

How chronic endometritis is diagnosed

Diagnosis usually relies on an endometrial biopsy assessed for stromal plasma cells, often with CD138 immunostaining and sometimes alongside hysteroscopy. Ultrasound cannot show this microscopic inflammation.

Common tools:

ToolClinical role
HysteroscopyMay show micropolyps, focal redness, or stromal swelling — clues, not proof
Endometrial biopsyObtains tissue from the cavity for histology
CD138 stainingHelps identify plasma cells; results must be interpreted with the histology and clinical context
Microbial cultureMay identify specific organisms; practice varies by centre

Ultrasound can miss chronic endometritis because the inflammation is microscopic. The lining may look normal in thickness and texture even when plasma cells are found in tissue. Biopsy is therefore the main diagnostic method, but there is no universally agreed plasma-cell threshold; CD138 findings need to be read with routine histology, biopsy timing, and the clinical history.

When it is usually investigated

Investigation may be considered when the history raises a specific concern, rather than as routine screening before a first IVF cycle.

Contexts in which clinicians may discuss an assessment include:

Routine endometrial biopsy before a first IVF cycle is not supported by high-level evidence. The value of testing depends on what has already happened. See our guide on hysteroscopy in female infertility.

Treatment for chronic endometritis

When chronic endometritis is confirmed, oral antibiotics may be offered according to the clinical context, local protocol, and microbiology where available. Whether to repeat the biopsy before transfer is an individual decision.

The choice of antibiotic and treatment length vary between centres. Culture results, previous treatment, allergies, and local resistance patterns may influence the plan.

Some teams recommend a test of cure — a second endometrial biopsy after treatment — particularly after recurrent implantation failure or when only a limited number of euploid embryos remain. It is not an automatic requirement for every patient.

Empirical antibiotics should not become routine after a failed transfer. Treatment should be considered after an individualized assessment and when endometrial tissue findings support the diagnosis; otherwise, patients may face side effects without proven benefit.

How successful is antibiotic treatment?

In one large retrospective series, a single course of oral antibiotics was followed by histological clearance in about 81% of cases. Women with documented clearance had higher pregnancy and live-birth rates in the next frozen transfer than women with persistent inflammation. That is a group result, not a personal forecast.

A cohort of 2,555 frozen-embryo-transfer cycles reported useful numbers for that setting. Among women diagnosed after implantation failure, one course of oral antibiotics cleared the inflammation in 80.7% of cases (309 of 383), confirmed on a repeat CD138 biopsy (Wei et al., 2026).

Women with documented histological clearance had higher clinical-pregnancy and live-birth rates in the next frozen transfer than those with persistent inflammation. This was an association in a retrospective, single-centre cohort of women treated after a first implantation failure; it does not prove that antibiotics caused the difference. A repeat biopsy can be clinically informative in selected cases because it documents whether plasma-cell inflammation is still present.

Dr. Aksoy’s clinical approach

Dr. Aksoy treats the roughly 81% histological-clearance figure as encouraging, not as proof that every patient is cured or will become pregnant. After recurrent implantation failure, or when few euploid embryos remain, he may recommend a control biopsy rather than assume that treatment worked. If inflammation persists, he reassesses the original diagnosis and looks for polyps, adhesions, or another focus in the cavity before considering further antibiotics. The decision is individualized; a control biopsy is not a routine formality for everyone.

What treatment does — and does not — promise

Resolution of confirmed chronic endometritis may remove a contributing factor, but it does not guarantee implantation or pregnancy. Embryo chromosomes, age, sperm factors, and transfer-related factors still matter.

Treating confirmed inflammation may improve the endometrial environment in selected patients. Pregnancy still depends on several other factors:

If transfers still fail after documented endometrial cure, the next step is a wider review — not another round of the same antibiotics. See our guide on what to review after IVF failure.

Request a Case Review

If a transfer has not worked and you want to know whether chronic endometritis, a cavity finding, or timing may have played a part, reviewing previous biopsy and hysteroscopy reports with a fertility specialist is a reasonable next step. You can contact the clinic to discuss which records are relevant before sending medical information.

Frequently Asked Questions

Can chronic endometritis be diagnosed on ultrasound alone?

No. Ultrasound cannot show microscopic plasma-cell infiltration. Diagnosis relies on an endometrial biopsy and histological examination, often supported by CD138 staining and interpreted in the clinical context.

Should every woman starting IVF undergo a biopsy for chronic endometritis?

No. Routine screening before a first IVF cycle is not supported by current evidence. Testing may be considered after an individualized assessment, particularly in recurrent implantation failure, recurrent pregnancy loss, or when the history or hysteroscopy raises a specific concern.

Does treating chronic endometritis guarantee IVF success?

No. In one retrospective cohort, histological inflammation cleared after one antibiotic course in about 81% of treated cases. That result cannot predict an individual outcome, and IVF success still depends on embryo chromosomal status, age, and other clinical factors.

How does chronic endometritis differ from acute endometritis?

Acute endometritis may present suddenly with fever, marked pelvic pain, and abnormal or pus-like discharge, and it requires prompt medical assessment. Chronic endometritis is usually low-grade and may cause few or no symptoms; it is identified through tissue examination.

Not routinely. Without a verified diagnosis, the possible harms — including side effects and antimicrobial resistance — may outweigh an uncertain benefit. The decision should follow an individual clinical assessment.

Sources

Next step

A question about your own case?

An article can set out the general picture, but not what applies to your own history. If you would like your situation looked at, you can send your questions and any previous reports to the medical team.

For privacy, please send only information needed for an initial reply. Ask the team which secure channel to use for medical reports or identity documents.

Request a medical review

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.